Bioresorbable Coronary Scaffolds: Current State of Evidence

Bioresorbable Coronary Scaffolds: Current State of Evidence

Second-generation drug-eluting stents are currently considered the standard of care in patients undergoing treatment for coronary artery disease with percutaneous coronary intervention. Despite significant improvements in stenting technology and stent material over the past three decades, the concer...

Full description

Bibliographic Details
Main Authors:	Sunny Goel, Shiv Raj, Abhishek Sharma, Umesh Gidwani, Robert Frankel, Jacob Shani
Format:	Article
Language:	English
Published:	European Medical Journal 2017-10-01
Series:	European Medical Journal Cardiology
Subjects:	Bioresorbable coronary scaffold (BCS) coronary artery disease percutaneous coronary coronary stenting in-stent restenosis stent thrombosis
Online Access:	https://www.emjreviews.com/cardiology/article/bioresorbable-coronary-scaffolds-current-state-of-evidence/

Similar Items

Bioresorbable scaffolds: current concepts and future technology
by: Debabrata Dash, et al.
Published: (2022-08-01)

Coronary Stent Strut Fractures: Classification, Prevalence and Clinical Associations
by: Katharina Schochlow, et al.
Published: (2021-04-01)

Recurrent atherosclerosis complications as a mechanism for stent failure
by: Ioannis Andreou, et al.
Published: (2020-01-01)

Nanoparticles-reinforced poly-l-lactic acid composite materials as bioresorbable scaffold candidates for coronary stents: insights from mechanical and finite element analysis
by: Toong, Daniel Wee Yee, et al.
Published: (2022)

Long-Term Outcomes After Implantation of Magnesium-Based Bioresorbable Scaffolds—Insights From an All-Comer Registry
by: Matthias Bossard, et al.
Published: (2022-04-01)

Bioresorbable Scaffolds: Current Evidences in the Treatment of Coronary Artery Disease
by: BHARGAV DAVE
Published: (2016-10-01)

Bioresorbable scaffolds: History and current knowledge
by: Min Ma, et al.
Published: (2016-01-01)

Vascular Wall Reactions to Coronary Stents—Clinical Implications for Stent Failure
by: Tommaso Gori
Published: (2021-01-01)

Restenosis after Coronary Stent Implantation: Cellular Mechanisms and Potential of Endothelial Progenitor Cells (A Short Guide for the Interventional Cardiologist)
by: Tommaso Gori
Published: (2022-06-01)

Everolimus-eluting bioresorbable scaffolds and metallic stents in diabetic patients: a patient-level pooled analysis of the prospective ABSORB DM Benelux Study, TWENTE and DUTCH PEERS
by: T. M. Hommels, et al.
Published: (2020-10-01)

Highlighting Hemodynamic Risks for Bioresorbable Stents in Coronary Arteries
by: Marcus S. Elliott, et al.
Published: (2023-08-01)

Bioresorbable vascular scaffold for coronary in-stent restenosis: A novel concept
by: Surender Deora, et al.
Published: (2014-07-01)

Quality of life of patients with coronary heart disease treated with the bioresorbable vascular scaffold (ABSORB™): 2-year results from the GABI-R-registry
by: Kathrin Pahmeier, et al.
Published: (2022-08-01)

Outcomes and prognostic factors of patients treated for in-stent restenosis: a retrospective single-center experience
by: Anis Ghariani, et al.
Published: (2022-05-01)

PERCUTANEOUS CORONARY INTERVENTIONS – CURRENT STATE OF DEVELOPMENT: STENTS EVOLUTION
by: Chernyak A. A., et al.
Published: (2020-11-01)

Impact of anemia on in-stent restenosis after percutaneous coronary intervention
by: Huilin Hu, et al.
Published: (2021-11-01)

The standard versus prolonged dual antiplatelet therapy after the XINSORB bioresorbable scaffold implantation (SPARTA) trial: study protocol for a randomized controlled trial
by: Yizhe Wu, et al.
Published: (2023-01-01)

Mechanism of Drug-Eluting Stent Thrombosis Diagnosed by Histopathological Evaluation of Directional Coronary Atherectomy Specimen
by: Kazuki Ito, MD, et al.
Published: (2023-12-01)

Effect of implantation technique on outcomes in patients receiving bioresorbable scaffolds in various clinical scenarios
by: Luis Ortega-Paz, et al.
Published: (2019-05-01)

Degradation modeling of poly-l-lactide acid (PLLA) bioresorbable vascular scaffold within a coronary artery
by: Lin Shengmao, et al.
Published: (2020-12-01)

One-Year Results of the Use of Absorb Bioresorbable Vascular Scaffold in Patients with Different Forms of Coronary Artery Disease as Compared to a Drug-Eluting Stent
by: Nabijon P. Yuldashev, et al.
Published: (2018-03-01)

In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: Clinical presentation, angiographic features, and outcomes
by: Ganesh Paramasivam, et al.
Published: (2019-12-01)

Bioresorbable Scaffolds: Contemporary Status and Future Directions
by: Xiang Peng, et al.
Published: (2020-11-01)

Variables asociadas a reestenosis clínica en pacientes con intervencionismo coronario percutáneo con stent convencional. Variables related to clinic restenosis in patients after percutaneous coronary interventionism with conventional stent.
by: Liz Álvarez González, et al.
Published: (2011-01-01)

Analysis of trends and prospects regarding stents for human blood vessels
by: Jeong Hee Lee, et al.
Published: (2018-03-01)

Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study
by: T. M. Hommels, et al.
Published: (2019-03-01)

Clinical profile and angiographic patterns of patients undergoing treatment for in-stent restenosis and outcomes associated with the treatment
by: Shivanand Patil, et al.
Published: (2020-01-01)

Coronary Artery Perforations: Glasgow Natural History Study of Covered Stent Coronary Interventions (GNOCCI) Study
by: Thomas J. Ford, et al.
Published: (2022-10-01)

One‐Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus‐Eluting Stents in High Bleeding Risk Patients
by: Carlo A. Pivato, et al.
Published: (2022-03-01)

Bioresorbable vascular stents and drug-eluting stents in treatment of coronary heart disease: a meta-analysis
by: Le Ni, et al.
Published: (2020-01-01)

Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds in real world patients
by: Beytullah Cakal, et al.
Published: (2020-12-01)

Relationship between the extent of coronary artery disease and in-stent restenosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
by: Erkan Yıldırım, et al.
Published: (2017-12-01)

Influence of metal alloy and the profile of coronary stents in patients with multivessel coronary disease
by: Luciano Maurício de Abreu Filho, et al.
Published: (2011-01-01)

Stent fracture: How frequently is it recognized?
by: Mohammed Khalil Mohsen, et al.
Published: (2013-01-01)

Effect of Epicardial Adipose Tissue on In-stent Restenosis after Percutaneous Coronary Intervention: a Review
by: AN Jingjing, WANG Xiaojuan, DENG Aiyun
Published: (2023-03-01)

The predictive value of preprocedural laboratory data in patients with coronary artery restenosis in various types of stents
by: D. V. Shames, et al.
Published: (2019-04-01)

Right coronary artery thrombosis within drug eluting stents more than 10 years after deployment: Two cases of very, very late stent thrombosis
by: Sam Lovibond, et al.
Published: (2017-09-01)

Factors Associated with Development of in Coronary Stent Restenosis — the Results of a Multislice Computed Tomography 1-year Follow-up Study
by: Jani Laura, et al.
Published: (2016-06-01)

CLINICAL CASE HISTORY OF EPTIFIBATIDE USE DURING CORONARY INTERVENTION IN PATIENT WITH CORONARY FAILURE
by: K. A. Kireev, et al.
Published: (2015-09-01)

Oral Health of Patients Undergoing Percutaneous Coronary Intervention—A Possible Link between Periodontal Disease and In-Stent Restenosis
by: Ferenc Tamás Nagy, et al.
Published: (2023-04-01)